The number of invasive glioma cells in the Transwell assay also decreased significantly after shLoxl1 knockdown (Figs. 7N, 7O), confirming that Loxl1 contributes to the invasion of glioma cells. The gene discussed is LOXL1; the disease is central nervous system cancer.